Jesper Brandgaard joined Novo Nordisk in 1999 as senior vice president of Corporate Finance and was appointed executive vice president in November 2000. He served also as chief financial officer from 2000 to 2018.
As executive vice president, Jesper Brandgaard is responsible for biopharm and legal affairs
Jesper Brandgaard serves as chairman of the board of SimCorp A/S, Denmark, and is a member of the Board of Chr. Hansen A/S, Denmark.
Jesper Brandgaard has an MSc in Economics and Auditing from 1990 as well as an MBA from 1995, both from the Copenhagen Business School, Denmark.
Jesper Brandgaard is a Danish national, born October 1963.
Jesper Brandgaard was elected Councillor of the Novo Nordisk Haemophilia Foundation in November 2017.